These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27012528)

  • 1. Molecular Docking, Metal Substitution and Hydrolysis Reaction of Chiral Substrates of Phosphotriesterase.
    de Castro AA; Caetano MS; Silva TC; Mancini DT; Rocha EP; da Cunha EF; Ramalho TC
    Comb Chem High Throughput Screen; 2016; 19(4):334-44. PubMed ID: 27012528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
    Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
    Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial characterization of an enzyme that hydrolyzes sarin, soman, tabun, and diisopropyl phosphorofluoridate (DFP).
    Little JS; Broomfield CA; Fox-Talbot MK; Boucher LJ; MacIver B; Lenz DE
    Biochem Pharmacol; 1989 Jan; 38(1):23-9. PubMed ID: 2910306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphotriesterase variants with high methylphosphonatase activity and strong negative trade-off against phosphotriesters.
    Briseño-Roa L; Timperley CM; Griffiths AD; Fersht AR
    Protein Eng Des Sel; 2011 Jan; 24(1-2):151-9. PubMed ID: 21037279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro.
    Goldsmith M; Eckstein S; Ashani Y; Greisen P; Leader H; Sussman JL; Aggarwal N; Ovchinnikov S; Tawfik DS; Baker D; Thiermann H; Worek F
    Arch Toxicol; 2016 Nov; 90(11):2711-2724. PubMed ID: 26612364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric biodegradation of the nerve agents Sarin and VX by human dUTPase: chemometrics, molecular docking and hybrid QM/MM calculations.
    de Castro AA; Soares FV; Pereira AF; Silva TC; Silva DR; Mancini DT; Caetano MS; da Cunha EFF; Ramalho TC
    J Biomol Struct Dyn; 2019 May; 37(8):2154-2164. PubMed ID: 30044197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogues with fluorescent leaving groups for screening and selection of enzymes that efficiently hydrolyze organophosphorus nerve agents.
    Briseño-Roa L; Hill J; Notman S; Sellers D; Smith AP; Timperley CM; Wetherell J; Williams NH; Williams GR; Fersht AR; Griffiths AD
    J Med Chem; 2006 Jan; 49(1):246-55. PubMed ID: 16392809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of nerve agents by an organophosphate-degrading agent (OpdA).
    Dawson RM; Pantelidis S; Rose HR; Kotsonis SE
    J Hazard Mater; 2008 Sep; 157(2-3):308-14. PubMed ID: 18258361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate Analogues for the Enzyme-Catalyzed Detoxification of the Organophosphate Nerve Agents-Sarin, Soman, and Cyclosarin.
    Bigley AN; Harvey SP; Narindoshvili T; Raushel FM
    Biochemistry; 2021 Sep; 60(38):2875-2887. PubMed ID: 34494832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymes for the homeland defense: optimizing phosphotriesterase for the hydrolysis of organophosphate nerve agents.
    Tsai PC; Fox N; Bigley AN; Harvey SP; Barondeau DP; Raushel FM
    Biochemistry; 2012 Aug; 51(32):6463-75. PubMed ID: 22809162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical Studies Applied to the Evaluation of the DFPase Bioremediation Potential against Chemical Warfare Agents Intoxication.
    Soares FV; de Castro AA; Pereira AF; Leal DHS; Mancini DT; Krejcar O; Ramalho TC; da Cunha EFF; Kuca K
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Today's threat of use of organophosphorus compounds].
    Sokołowski R; Płusa T
    Pol Merkur Lekarski; 2015 Sep; 39(231):176-80. PubMed ID: 26449583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the Challenges of Enzyme Evolution To Adapt Phosphotriesterase for V-Agent Decontamination.
    Bigley AN; Desormeaux E; Xiang DF; Bae SY; Harvey SP; Raushel FM
    Biochemistry; 2019 Apr; 58(15):2039-2053. PubMed ID: 30893549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
    Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
    Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective hydrolysis of organophosphate nerve agents by the bacterial phosphotriesterase.
    Tsai PC; Bigley A; Li Y; Ghanem E; Cadieux CL; Kasten SA; Reeves TE; Cerasoli DM; Raushel FM
    Biochemistry; 2010 Sep; 49(37):7978-87. PubMed ID: 20701311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrogation of the Substrate Profile and Catalytic Properties of the Phosphotriesterase from Sphingobium sp. Strain TCM1: An Enzyme Capable of Hydrolyzing Organophosphate Flame Retardants and Plasticizers.
    Xiang DF; Bigley AN; Ren Z; Xue H; Hull KG; Romo D; Raushel FM
    Biochemistry; 2015 Dec; 54(51):7539-49. PubMed ID: 26629649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Design of Phosphotriesterase Improves V-Agent Degradation Efficiency.
    Kronenberg J; Chu S; Olsen A; Britton D; Halvorsen L; Guo S; Lakshmi A; Chen J; Kulapurathazhe MJ; Baker CA; Wadsworth BC; Van Acker CJ; Lehman JG; Otto TC; Renfrew PD; Bonneau R; Montclare JK
    ChemistryOpen; 2024 Jul; 13(7):e202300263. PubMed ID: 38426687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of carboxylesterase in soman, sarin and tabun poisoning in rats.
    Jokanović M
    Pharmacol Toxicol; 1989 Sep; 65(3):181-4. PubMed ID: 2813290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-VX exposure treatment of rats with engineered phosphotriesterases.
    Stigler L; Köhler A; Koller M; Job L; Escher B; Potschka H; Thiermann H; Skerra A; Worek F; Wille T
    Arch Toxicol; 2022 Feb; 96(2):571-583. PubMed ID: 34962578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants of Phosphotriesterase for the Enhanced Detoxification of the Chemical Warfare Agent VR.
    Bigley AN; Mabanglo MF; Harvey SP; Raushel FM
    Biochemistry; 2015 Sep; 54(35):5502-12. PubMed ID: 26274608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.